Fidelity Investments
NPCE icon

Fidelity Investments’s Neuropace NPCE Stock Holding History

Fidelity Investments’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.28M Sell
553,529
-71,418
-11% -$1.07M ﹤0.01% 2167
2025
Q4 		$9.65M Buy
624,947
+625
+0.1% +$8.36K ﹤0.01% 2045
2025
Q3 		$6.44M Sell
624,322
-1,124
-0.2% -$10.6K ﹤0.01% 2153
2025
Q2 		$6.97M Buy
625,446
+375,541
+150% +$4.7M ﹤0.01% 2058
2025
Q1 		$3.07M Buy
249,905
+234
+0.1% +$2.93K ﹤0.01% 2318
2024
Q4 		$2.79M Buy
249,671
+261
+0.1% +$2.27K ﹤0.01% 2340
2024
Q3 		$1.74M Buy
249,410
+16
+0% +$117 ﹤0.01% 2437
2024
Q2 		$1.89M Sell
249,394
-53,409
-18% -$539K ﹤0.01% 2363
2024
Q1 		$4M Sell
302,803
-165,278
-35% -$2.36M ﹤0.01% 2135
2023
Q4 		$4.83M Sell
468,081
-238,164
-34% -$1.9M ﹤0.01% 2076
2023
Q3 		$6.87M Sell
706,245
-517,418
-42% -$3.03M ﹤0.01% 1944
2023
Q2 		$5.49M Sell
1,223,663
-269,268
-18% -$1.22M ﹤0.01% 2039
2023
Q1 		$6.93M Buy
1,492,931
+43,005
+3% +$165K ﹤0.01% 2001
2022
Q4 		$2.16M Hold
1,449,926
– – ﹤0.01% 2355
2022
Q3 		$5.44M Buy
1,449,926
+30,975
+2% +$149K ﹤0.01% 2141
2022
Q2 		$7.02M Buy
1,418,951
+11,645
+0.8% +$76.9K ﹤0.01% 2120
2022
Q1 		$11.6M Buy
1,407,306
+341,269
+32% +$2.94M ﹤0.01% 2053
2021
Q4 		$10.7M Buy
1,066,037
+652
+0.1% +$8.47K ﹤0.01% 2090
2021
Q3 		$16.9M Buy
1,065,385
+5,326
+0.5% +$112K ﹤0.01% 1918
2021
Q2 		$25.2M Buy
+1,060,059
New +$24.6M ﹤0.01% 1740

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments's NPCE Position: Q1 2026 in Review

Fidelity Investments reduced its Neuropace (NPCE) stake by 11% in Q1 2026, selling an estimated $1.07M and leaving 553,529 shares worth $7.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2167.

Fidelity Investments first reported a position in NPCE in Q2 2021 and has held it in 20 quarters since. The position peaked at $25.2M in Q2 2021. 113 funds tracked by Wall St. Rank hold NPCE as of Q1 2026.

  • Fidelity Investments held 553,529 shares of Neuropace worth $7.28M as of Q1 2026.
  • Fidelity Investments sold 71,418 Neuropace shares in Q1 2026, an estimated $1.07M.
  • Neuropace made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2167 holding.
  • Fidelity Investments first reported a position in Neuropace in Q2 2021 and has held it in 20 quarters since.
  • Fidelity Investments's Neuropace position peaked at $25.2M in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.